Core Insights - Microbix Biosystems Inc. has launched QUANTDx™, a new product line of reference materials aimed at supporting diagnostic assay manufacturers [1][2] - The QUANTDx product line includes over 80 reference materials covering six common disease panels, addressing a critical need in the infectious disease diagnostics industry [2][3] - The launch is expected to drive revenue growth and expand Microbix's global customer base, reflecting strong demand for high-quality reference materials [4] Company Overview - Microbix Biosystems Inc. specializes in creating proprietary biological products for human health, with a revenue target of C$ 2.0 million or more per month [5] - The company offers a range of critical ingredients and devices for the global diagnostics industry, including antigens for immunoassays and quality assessment products [5][6] - Microbix is ISO 9001 & 13485 accredited and registered with U.S. FDA, Australian TGA, and Health Canada, ensuring compliance with international standards [5] Product Details - QUANTDx features accurately-quantified and fully-traceable reference materials that help assay developers establish key analytical performance metrics essential for regulatory submissions [2][3] - The product line complements Microbix's existing Quality Assessment Products (QAPs™) portfolio, enhancing support throughout the diagnostic development lifecycle [3] - The initial launch of QUANTDx addresses the need for reliable and standardized reference materials in the diagnostics industry [2][3]
Microbix Launches QUANTDx™ Characterized Reference Materials